AQR Capital Management
SCMP

AQR Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

AQR Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,610
Closed -$715K – 2312
2017
Q3 		$715K Sell
60,610
-86,928
-59% -$975K ﹤0.01% 1799
2017
Q2 		$1.55M Buy
147,538
+37,397
+34% +$381K ﹤0.01% 1500
2017
Q1 		$1.21M Buy
110,141
+61,971
+129% +$719K ﹤0.01% 1594
2016
Q4 		$653K Sell
48,170
-27,279
-36% -$381K ﹤0.01% 1841
2016
Q3 		$929K Sell
75,449
-31,630
-30% -$373K ﹤0.01% 1740
2016
Q2 		$1.18M Sell
107,079
-132,140
-55% -$1.48M ﹤0.01% 1549
2016
Q1 		$2.61M Sell
239,219
-110,085
-32% -$1.39M ﹤0.01% 1129
2015
Q4 		$6.04M Buy
349,304
+126,985
+57% +$2.28M 0.01% 858
2015
Q3 		$4.42M Sell
222,319
-51,256
-19% -$1.18M 0.01% 852
2015
Q2 		$4.5M Buy
273,575
+174,389
+176% +$3.02M 0.01% 874
2015
Q1 		$1.54M Buy
+99,186
New +$1.54M ﹤0.01% 1219
2014
Q4 		– Sell
-13,000
Closed -$85K – 2703
2014
Q3 		$85K Hold
13,000
– – ﹤0.01% 2463
2014
Q2 		$90K Sell
13,000
-5,100
-28% -$36.1K ﹤0.01% 2471
2014
Q1 		$129K Buy
+18,100
New +$155K ﹤0.01% 2490

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AQR Capital Management's SCMP Position: Q4 2017 in Review

AQR Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 60,610 shares — an estimated $715K sold.

AQR Capital Management first reported a position in SCMP in Q1 2014 and held it in 14 quarters. The position peaked at $6.04M in Q4 2015. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • AQR Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • AQR Capital Management sold 60,610 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $715K.
  • AQR Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 14 quarters.
  • AQR Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $6.04M in Q4 2015.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on AQR Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.